Spectral Ai Stock Today
| MDAI Stock | 1.50 0.02 1.32% |
PerformanceSoft
| Odds Of DistressStrong
|
Spectral is trading at 1.50 as of the 18th of February 2026. This is a 1.32% down since the beginning of the trading day. The stock's open price was 1.52. Spectral has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of November 2025 and ending today, the 18th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 6th of April 2021 | Category Healthcare | Classification Health Care |
Spectral is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 30.69 M outstanding shares of which 1.48 M shares are now shorted by private and institutional investors with about 4.09 trading days to cover. More on Spectral AI
Moving against Spectral Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Spectral Stock Highlights
| CEO Director | Erich Spangenberg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [RBS M A DGL A C, RBS M A DGL A C] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDebt leverage enables Spectral to amplify potential investment gains using borrowed funds. Evaluating debt relative to total assets helps investors assess Spectral's financial structure and understand the extent to which Spectral's operations depend on creditor capital.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Spectral AI (MDAI) is traded on NASDAQ Exchange in USA and employs 78 people. Spectral is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.57 M. Spectral AI conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 30.69 M outstanding shares of which 1.48 M shares are now shorted by private and institutional investors with about 4.09 trading days to cover.
Spectral generates negative cash flow from operations
Check Spectral Probability Of Bankruptcy
Ownership AllocationSpectral AI shows a total of 30.69 Million outstanding shares. Spectral AI maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Spectral Ownership Details
Spectral Historical Income Statement
Spectral Stock Against Markets
Spectral Corporate Management
| Stan Micek | Interim Officer | Profile | |
| Jeffrey Thatcher | Chief Scientist | Profile | |
| Vincent Capone | General Secretary | Profile | |
| Christine Marks | Vice Commercialization | Profile | |
| Louis Percoco | General Manager | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Spectral AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is there potential for Health Care Equipment & Supplies market expansion? Will Spectral introduce new products? Factors like these will boost the valuation of Spectral. Expected growth trajectory for Spectral significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Spectral listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth (0.54) | Return On Assets | Return On Equity |
The market value of Spectral AI is measured differently than its book value, which is the value of Spectral that is recorded on the company's balance sheet. Investors also form their own opinion of Spectral's value that differs from its market value or its book value, called intrinsic value, which is Spectral's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Spectral's market value can be influenced by many factors that don't directly affect Spectral's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Spectral's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Spectral represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Spectral's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.